Navigation Links
Swelling of Prostate Gland Prevented with New drug

Estrogen regulating drugs might aid in prevention of enlargement of the prostate gland in older men according to Australian scientists. //

Results of animal studies that were presented at a medical conference in London showed that an experimental estrogen-regulating drug prevented the swelling of the prostate gland which occurs as men age.

Professor Gail Risbridger, of Monash University in Melbourne said, “We still have to try the drugs in humans, but so far these are very promising results.”

“This work holds out the possibility that we may be able to help patients with benign disease as well as men with prostate cancer by using these designer drugs.”

Enlarged prostate, or benign prostate hyperplasia (BPH) is a common disease in men over 60 causing urinary problems, infections and pain.

Although estrogen is generally considered a female hormone it also plays a role in the development of the prostate gland having both positive and negative effects.

Risbridger said, “There are two things that estrogens do, good and bad, but in different diseases.”

The bad effect is that the hormone can cause malignancy but on the positive side it can stop BPH from developing.

On testing an estrogen receptor-beta agonist on transgenic mice with BPH Risbridger and her team found that the drug activated just one of the two cell receptors for the hormone to produce the positive impact. This was presented at the Society for Endocrinology conference.

The scientists found that regulating the estrogen receptor beta stopped the development of benign prostate hyperplasia, while the negative effects were due to switching on the estrogen receptor alpha.

She said, “When you give one of the estrogen selective drugs that only activates a particular type of estrogen receptor, beta, you can prevent the hyperplasia from developing.”

The drug was found to stop the development of the illness and improve the health of the animals which had existing BPH.

Risbridger added, “Ideally, we would want to promote the good effects of estrogen receptor beta and block the bad effects of estrogen receptor alpha.”

“It’s interesting work, and we are pleased that preclinical testing may translate into real benefits for patients.”

Source-Medndia
NLA
'"/>




Related medicine news :

1. Swelling increases stroke risk with high B.P.
2. Do Not Neglect Your Abdominal Pain/ Swelling - Help Your Doctor In Early Cancer Detection
3. Brain Swelling Key to Reducing Stroke Fatalities
4. Surgeon Develops Procedure to Prevent Arm Swelling in Breast Cancer Patients
5. Cancer Doctors Okays Controversial Prostate Therapy
6. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
7. New Prostate Cancer Vaccine Shows Promise
8. Hormone Therapy applicable for Prostate Cancer
9. Prostate cancer and Vitamins
10. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
11. Early Detection Of Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: